Ian R. Wanless

15.8k total citations · 3 hit papers
105 papers, 8.9k citations indexed

About

Ian R. Wanless is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ian R. Wanless has authored 105 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hepatology, 58 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Ian R. Wanless's work include Liver Disease Diagnosis and Treatment (54 papers), Liver Disease and Transplantation (36 papers) and Liver Diseases and Immunity (14 papers). Ian R. Wanless is often cited by papers focused on Liver Disease Diagnosis and Treatment (54 papers), Liver Disease and Transplantation (36 papers) and Liver Diseases and Immunity (14 papers). Ian R. Wanless collaborates with scholars based in Canada, United States and United Kingdom. Ian R. Wanless's co-authors include Morris Sherman, Jenny Heathcote, Paul D. Greig, Gary Levy, Jorge Filmus, Mariana Capurro, Eiji Miyoshi, Gerrit DeBoer, Wen Shi and Masaya Tanaka and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Ian R. Wanless

103 papers receiving 8.6k citations

Hit Papers

Fatty liver hepatitis (steatohepatitis) and obesity: An a... 1990 2026 2002 2014 1990 1995 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
    1990 938 citations Ian R. Wanless et al. Hepatology profile →
  2. Terminology of nodular hepatocellular lesions
    1995 854 citations Ian R. Wanless Hepatology profile →
  3. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
    2003 733 citations Ian R. Wanless, Morris Sherman et al. Gastroenterology profile →

Peers

Ian R. Wanless
Calogero Cammà Italy
Raoul Poupon France
Rolf Hultcrantz Sweden
Marianne Ziol France
Bernard Portmann United Kingdom
Laura Rubbia‐Brandt Switzerland
Raoul Poupon France
Hari S. Conjeevaram United States
Kazuhide Yamamoto Japan
Christine Sempoux Belgium
Calogero Cammà Italy
Ian R. Wanless
Citations per year, relative to Ian R. Wanless Ian R. Wanless (= 1×) peers Calogero Cammà

Countries citing papers authored by Ian R. Wanless

Since Specialization
Citations

This map shows the geographic impact of Ian R. Wanless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Wanless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Wanless more than expected).

Fields of papers citing papers by Ian R. Wanless

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Wanless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Wanless. The network helps show where Ian R. Wanless may publish in the future.

Co-authorship network of co-authors of Ian R. Wanless

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Wanless. A scholar is included among the top collaborators of Ian R. Wanless based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Wanless. Ian R. Wanless is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clouston, Andrew D., Annette S.H. Gouw, Dina Tiniakos, et al.. (2024). Severe acute liver disease in adults: Contemporary role of histopathology. Histopathology. 85(4). 549–561. 5 indexed citations
2.
Torbenson, Michael, Valeer Desmet, Helmut Denk, et al.. (2020). Fifty years of impact on liver pathology: a history of the Gnomes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(2). 191–200. 1 indexed citations
3.
Keough, Valerie, et al.. (2012). Intra and extra-hepatic cystadenoma of the biliary duct. Review of literature and radiological and pathological characteristics of a very rare case. BMJ Case Reports. 2012. bcr0120125497–bcr0120125497. 25 indexed citations
4.
5.
Bioulac‐Sage, Paulette, Charles Balabaud, Pierre Bédossa, et al.. (2007). Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. Journal of Hepatology. 46(3). 521–527. 122 indexed citations
6.
Groot, Christianne J.M. de, et al.. (2005). CORRECTION. Gut. 54(7). 1050.1–1050. 6 indexed citations
7.
Feld, Jordan J., et al.. (2005). Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *. Hepatology. 42(1). 53–62. 250 indexed citations
8.
Wanless, Ian R., et al.. (2003). Pediatric-onset primary biliary cirrhosis. Gastroenterology. 125(5). 1476–1479. 54 indexed citations
9.
Wanless, Ian R.. (2002). Benign liver tumors. Clinics in Liver Disease. 6(2). 513–526. 23 indexed citations
10.
Cauch‐Dudek, Karen, et al.. (2000). Are Antibodies to Carbonic Anhydrase II Specific for Anti-Mitochondrial Antibody-Negative Primary Biliary Cirrhosis?. Digestive Diseases and Sciences. 45(10). 2018–2021. 19 indexed citations
11.
Hemming, Alan W., Ian R. Wanless, Mel Krajden, et al.. (1999). OUTCOME OF LONG-TERM RIBAVIRIN THERAPY FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION. Transplantation. 67(9). 1277–1280. 52 indexed citations
12.
Philosophe, Benjamin, Paul D. Greig, Alan W. Hemming, et al.. (1998). Surgical management of hepatocellular carcinoma: resection or transplantation?. Journal of Gastrointestinal Surgery. 2(1). 21–27. 51 indexed citations
13.
Wanless, Ian R., et al.. (1997). The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatology. 26(3). 554–560. 59 indexed citations
14.
Mastaï, Ricardo, Serge Laganiere, Ian R. Wanless, et al.. (1996). Hepatic Sinusoidal Fibrosis Induced by Cholesterol and Stilbestrol in the Rabbit: 2. Hemodynamic and Drug Disposition Studies. Hepatology. 24(4). 865–870. 9 indexed citations
15.
Wanless, Ian R., et al.. (1996). Fistula between duodenum and portal vein caused by peptic ulcer disease and complicated by hemorrhage and portal vein thrombosis.. PubMed. 91(7). 1462–3. 7 indexed citations
16.
Cattral, Mark S., Mel Krajden, Ian R. Wanless, et al.. (1996). A PILOT STUDY OF RIBAVIRIN THERAPY FOR RECURRENT HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION1. Transplantation. 61(10). 1483–1488. 54 indexed citations
17.
Sadowski, Daniel, Samuel S. Lee, Ian R. Wanless, James K. Kelly, & E. Jenny Heathcote. (1995). Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology. 21(4). 970–975. 53 indexed citations
18.
Wong, David, Colina Yim, Erluo Chen, et al.. (1995). Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population. Gastroenterology. 108(1). 165–171. 67 indexed citations
19.
Wanless, Ian R., Sylvain Doré, Jensen C. C. Tan, et al.. (1990). Histopathology of cocaine hepatotoxicity. Gastroenterology. 98(2). 497–501. 95 indexed citations
20.
Wanless, Ian R., Powers Peterson, Asha Das, et al.. (1990). Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy†. Hepatology. 12(5). 1166–1174. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Calogero Cammà Breakdown of academic impact, for papers by Raoul Poupon Breakdown of academic impact, for papers by Rolf Hultcrantz Breakdown of academic impact, for papers by Marianne Ziol Breakdown of academic impact, for papers by Bernard Portmann Breakdown of academic impact, for papers by Laura Rubbia‐Brandt Breakdown of academic impact, for papers by Raoul Poupon Breakdown of academic impact, for papers by Hari S. Conjeevaram Breakdown of academic impact, for papers by Kazuhide Yamamoto Breakdown of academic impact, for papers by Christine Sempoux
Rankless by CCL
2026